Hypercalcaemia - presentation and management
- PMID: 28572230
- PMCID: PMC6297576
- DOI: 10.7861/clinmedicine.17-3-270
Hypercalcaemia - presentation and management
Abstract
Hypercalcaemia is a common disorder normally caused by primary hyperparathyroidism (PHPT) or malignancy. A proportion of cases present as an emergency, which carries a significant mortality. Emergency management of hypercalcaemia is based on intravenous rehydration with normal saline but when this is inadequate, bisphosphonate therapy is used; more recently the novel anti-resorbtive agent denosumab has been shown to have a useful role in treatment. It is estimated that up to 10% of all cases of PHPT presenting under the age of 45 years have an underlying genetic predisposition; nine potentially causative genes are now recognised and may be screened in routine clinical practice. Although parathyroidectomy is the only curative treatment for PHPT, this is indicated in a minority of cases. Many cases can be adequately managed conservatively and guidance from the 4th international workshop on the management of asymptomatic PHPT has recently been updated in a consensus statement.
© Royal College of Physicians 2017. All rights reserved.
Figures

References
-
- Goltzman D. Approach to Hypercalcemia. In: De Groot LJ, editor; Chrousos G, editor; Dungan K, et al., editors. Approach to Hypercalcemia. South Dartmouth (MA): MDText.com, Inc.; 2000.
-
- Marcocci C. Cetani F. Primary hyperparathyroidism. N Engl J Med. 2011;365:2389–97. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources